β¨ Medicine Consents
NEW ZEALAND GAZETTE, No. 70
21 APRIL 2005
1680
Product:
Concerta Extended Release Tablets
Active Ingredient:
Methylphenidate hydrochloride 54mg
Dosage Form:
Modified release tablet
New Zealand Sponsor:
Janssen-Cilag Pty Limited
Manufacturers:
Alza Corporation, Mountain View, California, United States of America
Alza Corporation, Vacaville, California, United States of America
Product:
Efexor-XR
Active Ingredient:
Venlafaxine hydrochloride 169.7mg equivalent to 150mg venlafaxine
Dosage Form:
Modified release capsule
New Zealand Sponsor:
Wyeth (NZ) Limited
Manufacturer:
Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico
Product:
Efexor-XR
Active Ingredient:
Venlafaxine hydrochloride 84.85mg equivalent to 75mg venlafaxine
Dosage Form:
Modified release capsule
New Zealand Sponsor:
Wyeth (NZ) Limited
Manufacturer:
Wyeth Pharmaceuticals Company, Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico
Product:
Fragmin
Active Ingredient:
Dalteparin sodium 10,000IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Recip AB, Stockholm, Sweden
Product:
Fragmin
Active Ingredient:
Dalteparin sodium 12,500IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Recip AB, Stockholm, Sweden
Product:
Fragmin
Active Ingredient:
Dalteparin sodium 25,000IU/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Pfizer New Zealand Limited
Manufacturer:
Recip AB, Stockholm, Sweden
Product:
Pegasys
Active Ingredient:
Peginterferon alfa-2a 270Β΅g/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche Ltd, Basel, Switzerland
Product:
Pegasys
Active Ingredient:
Peginterferon alfa-2a 360Β΅g/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
F Hoffmann-La Roche Ltd, Basel, Switzerland
Product:
Xeloda
Active Ingredient:
Capecitabine 150mg
Dosage Form:
Film-coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturers:
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom
Product:
Xeloda
Active Ingredient:
Capecitabine 500mg
Dosage Form:
Film-coated tablet
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturers:
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Products Limited, Welwyn Garden City, Hertfordshire, United Kingdom
Dated this 14th day of April 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2403
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 70
Gazette.govt.nz —
NZ Gazette 2005, No 70
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Changed Medicines
(continued from previous page)
π₯ Health & Social Welfare14 April 2005
Medicines, Consent, Distribution, Concerta, Methylphenidate, Efexor-XR, Venlafaxine, Fragmin, Dalteparin, Pegasys, Peginterferon, Xeloda, Capecitabine
- DON MATHESON, Deputy Director-General, Public Health